Skip to content

Direct Pulp Capping Compared to Partial Pulpotomy in Carious Pulp Exposures

Outcome of Direct Pulp Capping Compared to Partial Pulpotomy in the Management of Carious Pulp Exposures in Mature Teeth: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06495242
Acronym
Pulp cap
Enrollment
120
Registered
2024-07-10
Start date
2023-03-25
Completion date
2027-12-02
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Caries

Keywords

Caries, pulpitis, direct pulp capping, partial pulpotomy,, pain

Brief summary

This a prospective randomized clinical trial that compare vital pulp therapy procedures in permanent teeth with carious pulp exposure. Patients are recruited from the dental teaching clinics at JUST following preset inclusion criteria. They are subsequently randomly assigned to one of treatment procedures. Clinical and radiographic follow up is performed after 6 months and yearly up to 5 years.

Detailed description

Background: Deep carious lesions are commonly encountered in both adults and children with no clear consensus on the ideal clinical management. Vital pulp therapy including direct pulp capping and pulpotomy is increasingly considered in the management of carious pulp exposures when the clinical diagnosis is reversible pulpitis with variable reports of success rates with different materials used and different diagnostic categories. Aims: The aims of this study are to evaluate the clinical and radiographic outcomes of direct pulp capping and partial pulpotomy in deep carious lesions of mature permanent teeth using a calcium silicate based material (Biodentine, Septodont, France), and to investigate the relationship between matrix metalloproteinase (MMP 9) levels in the pulpal blood and the outcome of these procedures. Methods: 120 mature molar teeth in 120 patients with deep carious lesions exposing the pulps on the radiograph and with symptoms of reversible pulpitis will be included in the study. The teeth will be subsequently randomly divided into 2 groups (n=60). One group will receive direct pulp capping and composite restoration, and the second group will receive partial pulpotomy and composite restoration. Pulpal blood will be collected from the exposure site and will be tested for the level of MMP9 using special ElISA kit. Preoperative and postoperative pain level at 48 hours and 7 days will be evaluated on a scale from 0-10. The treated teeth will be further evaluated clinically and radiographically at 6 and 12 months follow up and yearly afterward. The relationship of the outcome to the level of MMP9 will be investigated. The results will be statistically analyzed using appropriate tests in the SPSS software. Expected results: Since partial pulpotomy includes the removal of 2-3 mm of the exposed pulp tissue which is theoretically inflamed, it is expected to be more effective in alleviating the patient's symptoms and to have a higher success rate than simply pulp capping the carious exposure. High levels of MMP9 are also expected to have a correlation with the failure rate.

Interventions

PROCEDUREDirect pulp capping and partial pulpotomy

Two types of vital pulp therapy procedures

Sponsors

King Abdullah University Hospital
Lead SponsorOTHER
Jordan University of Science and Technology
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

the participants are blinded to the type of treatment provided, the care provider is masked only during the early stages of teh procedure but subsequently masking is not possible due to different treatment protocols. Block randomization. and sealed envelop technique are used. Principal investigator and evaluator are blinded to the type of treatment provided

Intervention model description

Parallel randomized clinical trial including 2 treatment groups with 1;1 allocation ration

Eligibility

Sex/Gender
ALL
Age
12 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Non -contributory medical history (ASA 1) * Molar tooth with extremely deep caries extending\>2/3 of dentin or exposing the pulp on the periapical radiograph * The tooth should give positive response to cold testing * Clinical diagnosis of reversible pulpitis with mild to moderate symptoms * The tooth is restorable, probing pocket depth and mobility are within normal limits * No signs of pulpal necrosis including sinus tract or swelling * No radiographic evidence of periapical changes indicative of apical periodontitis

Exclusion criteria

Immature teeth * Nonvital teeth * Irreversible pulpitis and periapical periodontitis, i.e spontaneous and lingering pain. * Inability to achieve hemostasis after 6 minutes of application of 5% NaOCl moist pellet * No pulp exposure after nonselective caries removal

Design outcomes

Primary

MeasureTime frameDescription
Short term clinical outcomeone weekResolution of clinical symptoms

Secondary

MeasureTime frameDescription
long term outcome1-5 yearsMaintenance of pulp vitality

Countries

Jordan

Contacts

PRINCIPAL_INVESTIGATORProf Nessrin A Taha, PhD

Jordan University of Science and Technology

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026